We a good story
Quick delivery in the UK

Indacaterol

- The First Once-daily Long-acting Beta2 Agonist for COPD

About Indacaterol

Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled beta2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.

Show more
  • Language:
  • English
  • ISBN:
  • 9783034807081
  • Binding:
  • Hardback
  • Pages:
  • 146
  • Published:
  • November 26, 2013
  • Edition:
  • 2014
  • Dimensions:
  • 155x235x15 mm.
  • Weight:
  • 3613 g.
Delivery: 2-3 weeks
Expected delivery: December 8, 2024

Description of Indacaterol

Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled beta2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.

User ratings of Indacaterol



Find similar books
The book Indacaterol can be found in the following categories:

Join thousands of book lovers

Sign up to our newsletter and receive discounts and inspiration for your next reading experience.